REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Canaccord Genuity 44th Annual Growth Conference in Boston, MA. Seer's management is scheduled to participate in a fireside chat on Wednesday, August 14th at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the session will be available on the Invest ...

Seer, Inc. (NASDAQ:SEER) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - CEO and Chair David Horn - President and CFO Conference Call Participants Operator Thank you for standing by. My name is Kathleen and I will be your conference operator today. At this time, I would like to welcome everyone to the Seer Incorporated Second Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After t ...

Seer, Inc. (SEER) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.37 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 2.78%. A quarter ago, it was expected that this company would post a loss of $0.31 per share when it actually produced a loss of $0.32, delivering a surprise of -3.23%. Over the last four quarters, the company has surpassed co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number 001-39747 SEER, INC. (Exact name of Registrant as specified in its charter) Delaware 82-1153150 ( ...

Seer Reports Second Quarter 2024 Financial Results Launched STAC in Europe and additional customer papers published in leading journals REDWOOD CITY, Calif. Aug 8, 2024 – Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2024. Recent Highlights • Achieved revenue of $3.1 million for the second quarter of 2024 • Launched the Seer Technology Access Center (STAC) in Europe, ...

REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Se ...

REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer's website at investor.seer.bio. An ...

Core Insights - Strategic Environmental & Energy Resources, Inc. (SEER) has received a purchase order worth approximately $600,000 from Biochar Now, LLC (BCN) for the provision of kilns as part of BCN's nationwide expansion program [1][6] - BCN, in collaboration with AgriCap Group, LLC, has launched an "Insured Carbon" program that offers fully insured biochar carbon credits, enhancing the reliability and marketability of its carbon credits in the global market [2][11] - SEER is actively pursuing the establishment of a joint venture facility in Texas with BCN to produce biochar and is exploring the processing of fiberglass waste and other composites at this facility [3][12] Company Overview - SEER specializes in identifying, securing, and commercializing patented environmental clean technologies across various sectors, including oil & gas, renewable fuels, and waste management [4] - The company operates through two wholly-owned subsidiaries and two majority-owned subsidiaries, focusing on minimizing hazardous waste streams and processing waste into renewable fuels [4] Strategic Partnerships and Growth - SEER's collaboration with BCN is aimed at developing cost-effective kiln manufacturing processes to enhance biochar production efficiency and minimize capital expenditures for new production sites [6][10] - BCN has established five operational locations and is developing additional biochar production sites across North America and Southeast Asia, indicating a strong growth trajectory [6] - SEER's involvement in the biochar market is expected to create multiple revenue streams, including kiln sales, product sales, and carbon credit sales, thereby increasing shareholder equity [12]

Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Omid Farokhzad, M.D., Chair & Chief Executive Officer of Seer said, "Exploring the effects of space flight on the human body presents an intriguing frontier for proteomic research. These papers highlight Seer's technology to provide unbiased insights into the proteome and shed light on dysfunctional biological alterations. At Seer, we empower researchers in detecting proteins and pept ...

Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Omid Farokhzad, M.D., Chair & Chief Executive Officer of Seer said, "Exploring the effects of space flight on the human body presents an intriguing frontier for proteomic research. These papers highlight Seer's technology to provide unbiased insights into the proteome and shed light on dysfunctional biological alterations. At Seer, we empower researchers in detecting proteins and pept ...